MediWound Ltd. (MDWD)

MediWound Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	19.85	18.69	26.5	23.76	21.76	31.79
Revenue Growth (YoY)	-23.32%	-29.48%	11.50%	9.19%	-31.54%	834.70%
Cost of Revenue	16.49	15.11	13.33	14.99	14.22	11.85
Gross Profit	3.36	3.58	13.17	8.77	7.55	19.94
Selling, General & Admin	11.4	11.61	10.65	9.74	8.69	9.31
Research & Development	6.84	7.47	10.18	10.26	7.7	4.97
Other Operating Expenses	0	0	0.68	0	0	1.17
Operating Expenses	18.23	19.08	21.51	19.99	16.39	15.45
Operating Income	-14.87	-15.5	-8.35	-11.22	-8.84	4.49
Interest Expense / Income	3.72	-8.76	11.64	2.31	1.28	2.98
Other Expense / Income	-6.04	-0.21	-0.46	-0.01	-0.92	-3.45
Pretax Income	-12.55	-6.53	-19.52	-13.52	-9.2	4.96
Income Tax	0.2	0.19	0.08	0.03	0	0
Net Income	-12.75	-6.72	-19.6	-13.55	-9.2	4.96
Shares Outstanding (Basic)	9	9	5	4	4	4
Shares Outstanding (Diluted)	9	9	5	4	4	4
Shares Change	10.09%	80.73%	28.13%	0.24%	0.00%	0.24%
EPS (Basic)	-1.38	-0.75	-3.93	-3.48	-2.38	1.26
EPS (Diluted)	-1.38	-0.75	-3.93	-3.48	-2.38	1.26
Free Cash Flow	-21.94	-16.93	-12.44	-9.41	-7.82	7.5
Free Cash Flow Per Share	-2.38	-1.88	-2.49	-2.42	-2.01	1.93
Gross Margin	16.92%	19.15%	49.69%	36.91%	34.67%	62.73%
Operating Margin	-74.91%	-82.96%	-31.50%	-47.22%	-40.62%	14.13%
Profit Margin	-64.24%	-35.94%	-73.97%	-57.03%	-42.26%	15.59%
Free Cash Flow Margin	-110.54%	-90.60%	-46.95%	-39.58%	-35.92%	23.58%
EBITDA	-7.46	-13.99	-6.61	-9.97	-6.83	9.09
EBITDA Margin	-37.60%	-74.85%	-24.95%	-41.96%	-31.37%	28.59%
Depreciation & Amortization	1.37	1.3	1.27	1.24	1.09	1.15
EBIT	-8.83	-15.29	-7.88	-11.21	-7.92	7.94
EBIT Margin	-44.49%	-81.83%	-29.76%	-47.17%	-36.38%	24.97%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).